Curocell (XKRX:372320) ROCE % : -79.36% (As of Jun. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Curocell ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Curocell's annualized ROCE % for the quarter that ended in Jun. 2023 was -79.36%.

Curocell ROCE % Historical Data

The historical data trend for Curocell's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curocell ROCE % Chart

Curocell Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

-3,710.48

-65.59

Curocell Semi-Annual Data
	Jun22	Dec22	Jun23	Dec23
ROCE %	-	-	-79.36	-34.13

Curocell ROCE % Calculation

Curocell's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-27232.94	/	( ( (87987.733 - 106647.939)	+	(104969.386 - 3270.412) )	/ 2 )
	=	-27232.94	/	( (-18660.206	+	101698.974)	/ 2 )
	=	-27232.94	/	41519.384
	=	-65.59 %

Curocell's ROCE % of for the quarter that ended in Jun. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Jun. 2023 )		(Q: Dec. 2022 )		(Q: Jun. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Jun. 2023 )		(Q: Dec. 2022 )		(Q: Jun. 2023 )
	=	-23721.68	/	( ( (87987.733 - 106647.939)	+	(88392.885 - 9948.815) )	/ 2 )
	=	-23721.68	/	( ( -18660.206	+	78444.07 )	/ 2 )
	=	-23721.68	/	29891.932
	=	-79.36 %

(1) Note: The EBIT data used here is two times the semi-annual (Jun. 2023) EBIT data.

Curocell (XKRX:372320) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Curocell ROCE % Related Terms

Thank you for viewing the detailed overview of Curocell's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Curocell (XKRX:372320) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Curocell Inc (XKRX:372320) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

11, Gukjegwahak 16-ro, Yuseong-gu, Daejeon, KOR, 34002

Website

https://www.curocellbtx.com

Curocell Inc is engaged in medical and pharmaceutical research and development. The company is into development of CAR-T treatments that enhance the natural function of immune cells to eliminate cancer cells through genetic manipulation of human immune cells.

Curocell (XKRX:372320) Headlines

No Headlines